FDA Not Quite Sold on Polivy in Frontline Large B-Cell Lymphoma Regimen

(MedPage Today) -- The FDA's Oncologic Drugs Advisory Committee (ODAC) will meet Thursday to consider whether results from the POLARIX trial support a favorable benefit-risk assessment for adult patients with previously untreated large B-cell lymphoma...
Source: MedPage Today Public Health - Category: American Health Source Type: news